Platelet transfusions are frequently given to neonatal intensive care unit (NICU) patients with
severe thrombocytopenia (platelets less than 50× 109 L− 1) but no study has assessed …

Riboflavin is a naturally occurring compound and an essential human nutrient. Studies in the
1960s and 70s showed that it could be effective, when exposed to visible or UV light, in …

BACKGROUND: Bacterial contamination of blood components can result in transfusion‐
transmitted infection, but the risk is not established. STUDY DESIGN AND METHODS …

Objective: To receive and collate reports of death or major complications of transfusion of
blood or components. Design: Haematologists were invited confidentially to report deaths …

The risk of blood transfusion-associated complications has been reduced in the past 10
years through technical advances in testing of blood, viral inactivation of noncellular blood …

Background: A photochemical treatment (PCT) process for inactivation of infectious
pathogens and leukocytes has been developed and evaluated using single-donor platelet …

Introduction: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a relatively rare
but potentially lethal disease, leading to severe bleeding complications in 1 in 11.000 …

Severe transfusion reactions associated with bacteria and/or their products, during or
following a blood transfusion, were one of the earliest recognized complications of …

OBJECTIVE: Necrotizing enterocolitis (NEC), a serious multisystemic inflammatory disease
most commonly seen in premature neonates, is often associated with thrombocytopenia …

Background and Objectives: A photochemical process has been tested for the inactivation of
viruses and bacteria in buffy–coat derived platelet concentrates (BC PCs). Materials and …